FDA Approves Merck's Heart-Attack Prevention Drug

The US Food and Drug Administration recently approved a new drug by Merck that lowers the risk of heart attacks and cardiovascular actions associated with peripheral arterial disease.

Zontivity was found to reduce rates of death from cardiovascular trauma over the three years it was measured.

 What is a Heart Attack?

A heart attack happens when blood flow to the heart abruptly becomes blocked and the heart does not get oxygen. When not treated quickly, the heart muscle fails to pump and an individual may begin to die.

Read the Entire Story... FDA Approves Merck's Heart-Attack Prevention Drug